Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.81)
# 3,305
Out of 5,127 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $30.06 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $29.34 | +134.32% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $1.64 | +326.83% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.81 | +1,749.34% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $360 | $1.43 | +25,163.16% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $102.87 | -65.98% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $16.86 | +196.56% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $2,470 → $1,520 | $6.54 | +23,141.59% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $8.75 | +1,100.00% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $39.38 | -26.36% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $5.27 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $30.06
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $29.34
Upside: +134.32%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $1.64
Upside: +326.83%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.81
Upside: +1,749.34%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $360
Current: $1.43
Upside: +25,163.16%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $102.87
Upside: -65.98%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $16.86
Upside: +196.56%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $2,470 → $1,520
Current: $6.54
Upside: +23,141.59%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $8.75
Upside: +1,100.00%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $39.38
Upside: -26.36%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $5.27
Upside: -